Explore

Trendline Trendline
Citeline Reports First Decline in Pharma Pipeline Since 1990s, Impacting Drug Development

Citeline Reports First Decline in Pharma Pipeline Since 1990s, Impacting Drug Development

Citeline Reports First Decline in Pharma Pipeline Since 1990s, Impacting Drug Development
Trendline Trendline
FDA Reversals in Rare Disease Trials Highlight Challenges with External Controls

FDA Reversals in Rare Disease Trials Highlight Challenges with External Controls

FDA Reversals in Rare Disease Trials Highlight Challenges with External Controls
Trendline Trendline
Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights
Trendline Trendline
API's Lean Derisking Strategy Aims to Streamline Drug Development

API's Lean Derisking Strategy Aims to Streamline Drug Development

API's Lean Derisking Strategy Aims to Streamline Drug Development
Trendline Trendline
Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom

Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom

Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom
Trendline Trendline
Pharma M Activity Surges with Record Highs Anticipated in 2026

Pharma M Activity Surges with Record Highs Anticipated in 2026

Pharma M Activity Surges with Record Highs Anticipated in 2026
Trendline Trendline
Eli Lilly's New GLP-1 Drugs Set to Transform Food and Beverage Industry

Eli Lilly's New GLP-1 Drugs Set to Transform Food and Beverage Industry

Eli Lilly's New GLP-1 Drugs Set to Transform Food and Beverage Industry
Trendline Trendline
TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records

TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records

TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records
Trendline Trendline
SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio

SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio

SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio
Trendline Trendline
Eli Lilly's New GLP-1 Drug Approval Set to Transform Weight Loss Market

Eli Lilly's New GLP-1 Drug Approval Set to Transform Weight Loss Market

Eli Lilly's New GLP-1 Drug Approval Set to Transform Weight Loss Market
Trendline Trendline
FDA Approves Eli Lilly's Foundayo, Expanding Obesity Treatment Options

FDA Approves Eli Lilly's Foundayo, Expanding Obesity Treatment Options

FDA Approves Eli Lilly's Foundayo, Expanding Obesity Treatment Options
Trendline Trendline
Immunovant's Batoclimab Fails Phase 3 Trials, Impacting Thyroid Eye Disease Treatment Plans

Immunovant's Batoclimab Fails Phase 3 Trials, Impacting Thyroid Eye Disease Treatment Plans

Immunovant's Batoclimab Fails Phase 3 Trials, Impacting Thyroid Eye Disease Treatment Plans